- Home
- WFRD vs ELAN Comparison
WFRD vs ELAN Comparison
Compare WFRD & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- ELAN
- Stock Information
- Founded
- WFRD 1941
- ELAN 1954
- Country
- WFRD United States
- ELAN United States
- Employees
- WFRD N/A
- ELAN N/A
- Industry
- WFRD Metal Fabrications
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- ELAN Health Care
- Exchange
- WFRD Nasdaq
- ELAN Nasdaq
- Market Cap
- WFRD 5.4B
- ELAN 6.3B
- IPO Year
- WFRD N/A
- ELAN 2018
- Fundamental
- Price
- WFRD $73.26
- ELAN $12.03
- Analyst Decision
- WFRD Strong Buy
- ELAN Buy
- Analyst Count
- WFRD 8
- ELAN 7
- Target Price
- WFRD $140.50
- ELAN $16.43
- AVG Volume (30 Days)
- WFRD 968.7K
- ELAN 3.8M
- Earning Date
- WFRD 02-05-2025
- ELAN 02-24-2025
- Dividend Yield
- WFRD 1.36%
- ELAN N/A
- EPS Growth
- WFRD 51.37
- ELAN N/A
- EPS
- WFRD 7.14
- ELAN 0.41
- Revenue
- WFRD $5,534,000,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- WFRD $10.75
- ELAN $2.22
- Revenue Next Year
- WFRD $0.79
- ELAN $2.72
- P/E Ratio
- WFRD $10.26
- ELAN $29.13
- Revenue Growth
- WFRD 11.08
- ELAN 1.99
- 52 Week Low
- WFRD $66.23
- ELAN $11.11
- 52 Week High
- WFRD $135.00
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- WFRD 50.12
- ELAN 48.98
- Support Level
- WFRD $68.46
- ELAN $11.11
- Resistance Level
- WFRD $74.90
- ELAN $12.19
- Average True Range (ATR)
- WFRD 2.79
- ELAN 0.38
- MACD
- WFRD 0.68
- ELAN 0.07
- Stochastic Oscillator
- WFRD 70.25
- ELAN 70.77
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.